Yuu Osanai
Tohoku Pharmaceutical University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yuu Osanai.
Bioorganic & Medicinal Chemistry | 2008
Koji Uwai; Yuu Osanai; Takuma Imaizumi; Syu-ichi Kanno; Mitsuhiro Takeshita; Masaaki Ishikawa
Caffeic acid esters, one of the components of propolis, are known to show a variety of biological effects such as anti-tumor, anti-oxidant, and anti-inflammatory activities. Although, the anti-inflammatory activities of caffeic acid esters have been studied by analyzing their structure, the detailed mechanisms of their activities remain unclear. Thus, in this study, we examined the function of the ester functional group and the alkyl side chain (alcoholic part) and transformed caffeic acid to several derivatives. The inhibitory effect of these derivatives on NO production in murine macrophage RAW264.7 cells was dependent on the length and size of the alkyl moiety, and undecyl caffeate was the most potent inhibitor of NO production. In addition, individual experiments using undecanol, caffeic acid, undecanol plus caffeic acid, and undecyl caffeate showed that the connection between caffeic acid and the alkyl chain is critical for activity. Amide and ketone derivatives showed that not only the ester functional group but also the amide and ketone functional groups exhibit an inhibitory effect on NO production.
Oncology Reports | 2013
Ayako Tomizawa; Syu-ichi Kanno; Yuu Osanai; Akane Goto; Chizuru Sato; Shin Yomogida; Masaaki Ishikawa
Caffeic acid esters have various biological activities, and we previously reported that undecyl caffeate (caffeic acid undecyl ester, CAUE), a new caffeic acid derivative, has strong pharmacological activity. The present study investigated the cytotoxicity of both CAUE and its parent compound, caffeic acid phenethyl ester (CAPE), and characterized the mechanisms by which they induce apoptosis in the human B cell leukemia cell line NALM-6. Treatment with CAUE reduced cell survival in NALM-6 cells but had no significant effect on the survival of normal lymphocytes. When assessing the 50% inhibitory concentration (IC50) for cytotoxicity, CAUE had 10-fold higher activity than CAPE in NALM-6 cells. CAUE treatment resulted in induction of apoptotic features in NALM-6 cells, including cleaved poly (ADP-ribose) polymerase and activated caspase-3. A caspase inhibitor completely blocked CAUE-induced apoptosis. CAUE treatment resulted in a concentration- and time-dependent decrease in both mitochondrial membrane potential and downregulation of Bcl-2 expression. Moreover, CAUE-induced apoptosis was enhanced in the Bcl-2 knockdown condition induced by small interfering RNA. These data suggest that CAUE-induced apoptosis was mediated via an apoptotic intrinsic pathway including mitochondrial damage and was caspase-dependent. These data also suggest that CAUE is a powerful anti-leukemic agent that acts via induction of apoptosis by mitochondrial damage and selective action in leukemia cells.
Biological & Pharmaceutical Bulletin | 2005
Syu-ichi Kanno; Ayako Tomizawa; Takako Hiura; Yuu Osanai; Ai Shouji; Mayuko Ujibe; Takaharu Ohtake; Katsuhiko Kimura; Masaaki Ishikawa
Life Sciences | 2006
Syu-ichi Kanno; Ai Shouji; Ayako Tomizawa; Takako Hiura; Yuu Osanai; Mayuko Ujibe; Yutaro Obara; Norimichi Nakahata; Masaaki Ishikawa
Biological & Pharmaceutical Bulletin | 2008
Syu-ichi Kanno; Yasue Kitajima; Mai Kakuta; Yuu Osanai; Kaori Kurauchi; Mayuko Ujibe; Masaaki Ishikawa
Biological & Pharmaceutical Bulletin | 2006
Syu-ichi Kanno; Ayako Tomizawa; Takako Hiura; Yuu Osanai; Mai Kakuta; Yasue Kitajima; Kimiko Koiwai; Takaharu Ohtake; Mayuko Ujibe; Masaaki Ishikawa
Biological & Pharmaceutical Bulletin | 2007
Syu-ichi Kanno; Takako Hiura; Ai Shouji; Yuu Osanai; Mayuko Ujibe; Masaaki Ishikawa
Biological & Pharmaceutical Bulletin | 2007
Syu-ichi Kanno; Mai Kakuta; Yasue Kitajima; Yuu Osanai; Kaori Kurauchi; Takaharu Ohtake; Mayuko Ujibe; Kouji Uwai; Mitsuhiro Takeshita; Masaaki Ishikawa
Basic & Clinical Pharmacology & Toxicology | 2006
Syu-ichi Kanno; Kohji Uwai; Ayako Tomizawa; Takako Hiura; Yuu Osanai; Mayuko Ujibe; Mitsuhiro Takeshita; Takaharu Ohtake; Katsuhiko Kimura; Masaaki Ishikawa
Journal of Pharmacological Sciences | 2007
Syu-ichi Kanno; Mai Kakuta; Yasue Kitajima; Yuu Osanai; Kaori Kurauchi; Takaharu Ohtake; Mayuko Ujibe; Kouji Uwai; Mituhiro Takeshita; Masaaki Ishikawa